Home
About Us
Partnership & Collaborations
News
Contact
Pharmacelera-Welab partnership agreement
30
Jan, 23
Barcelona, January 27th, 2023
Read More
Spirify – Welab Barcelona research collaboration
14
Nov, 22
WeLab Barcelona has reached an agreement with Spirify Pharma for
Read More
Carcinogenicity studies of cizolirtine, a substance-P and calcitonin gene-related peptide release modulator
1
Aug, 22
Check out the new Welab’s publication on toxicological profile of
Read More
Comprehensive Preclinical Assessment of Sensory, Functional, Motivational-Affective, and Neurochemical Outcomes in Neuropathic Pain
1
Aug, 22
Check out the recent Welab’s publication on alternative methods for
Read More
Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development
1
Aug, 22
Check out the IMI-PainCare project publication, with the contribution of
Read More
New publication in ACS Medicinal Chemistry Letters
13
Jun, 22
Check out the new Welab’s publication in the Virtual Special
Read More
IMI-Paincare General Assembly
8
Apr, 22
We have participated in the General Assembly of the IMI-PainCare
Read More
Welab is GLP certified R&D site
30
Mar, 22
Welab Barcelona has been certified by the competent authority as
Read More
Welab has signed an Agreement with the consortium IMI-Paincare, through the partner Consultech GmbH
7
Jun, 21
IMI-Paincare is the biggest European consortium in the pain field,
Read More
ESTEVE and LEITAT announce strategic partnership to collaborate in research and development
9
Jul, 20
An alliance to create WeLab, a bio incubator, accelerator hub
Read More